James Mulshine to Cost-Benefit Analysis
This is a "connection" page, showing publications James Mulshine has written about Cost-Benefit Analysis.
Connection Strength
0.319
-
Issues with implementing a high-quality lung cancer screening program. CA Cancer J Clin. 2014 Sep-Oct; 64(5):352-63.
Score: 0.112
-
Lung cancer screening. Oncologist. 2006 May; 11(5):481-7.
Score: 0.064
-
Clinical issues in the management of early lung cancer. Clin Cancer Res. 2005 Jul 01; 11(13 Pt 2):4993s-4998s.
Score: 0.060
-
Lung cancer screening with spiral CT: toward a working strategy. Oncology (Williston Park). 2004 May; 18(5):564-75, discussion 578, 583-4, 587.
Score: 0.056
-
The International Association Study Lung Cancer (IASLC) Strategic Screening Advisory Committee (SSAC) response to the USPSTF recommendations. J Thorac Oncol. 2014 Feb; 9(2):141-3.
Score: 0.027